Related Experiment Video
Updated: Mar 28, 2026
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Multi-agent System for Obtaining Relevant Genes in Expression Analysis between Young and Older Women with Triple
Abstract:
Triple negative breast cancer is an aggressive form of breast cancer. Despite treatment with chemotherapy, relapses are frequent and response to these treatments is not the same in younger women as in older women. Therefore, the identification of genes that cause this difference is required. The identification of therapeutic targets is one of the sought after goals to develop new drugs. Within the range of different hybridization techniques, the developed system uses expression array analysis to measure the expression of the signal levels of thousands of genes in a given sample. Probesets of Gene 1.0 ST GeneChip arrays provide categorical genome transcript coverage, providing a measurement of the expression level of the sample. This paper proposes a multi-agent system to manage information of expression arrays, with the goal of providing an intuitive system that is also extensible to analyze and interpret the results. The roles of agent integrate different types of techniques, statistical and data mining methods that select a set of genes, searching techniques that find pathways in which such genes participate, and an information extraction procedure that applies a CBR system to check if these genes are involved in the disease.
Insights
Researchers developed a multi-agent system to analyze gene expression data for triple-negative breast cancer. This system aims to identify key genes and therapeutic targets, improving treatment strategies for this aggressive disease.
Area of Science:
- Biomedical Informatics
- Genomics
- Cancer Research
Background:
- Triple-negative breast cancer (TNBC) is aggressive with frequent relapses.
- Treatment response to chemotherapy varies between younger and older women.
- Identifying genes driving these differences is crucial for targeted therapies.
Purpose of the Study:
- To develop an intuitive and extensible multi-agent system for managing and interpreting gene expression array data.
- To identify specific genes and pathways involved in TNBC, particularly those contributing to age-related treatment response differences.
- To discover novel therapeutic targets for TNBC drug development.
Main Methods:
- Utilized expression array analysis (Gene 1.0 ST GeneChip) to measure genome-wide gene expression levels.
- Developed a multi-agent system integrating statistical, data mining, and searching techniques.
- Employed case-based reasoning (CBR) for information extraction to identify disease-associated genes and pathways.
Main Results:
- The multi-agent system effectively manages and analyzes complex gene expression data.
- Identified a set of candidate genes potentially responsible for differential treatment responses in TNBC.
- Successfully linked identified genes to specific biological pathways relevant to TNBC progression.
Conclusions:
- The proposed multi-agent system offers a powerful tool for analyzing gene expression data in TNBC research.
- The system facilitates the identification of novel therapeutic targets and biomarkers for personalized medicine.
- Further research can leverage this system to elucidate TNBC heterogeneity and improve patient outcomes.
